Since its earliest use, the Magtrace® lymphatic tracer has been subject to numerous regulatory approvals, clinical studies and peer-review papers.
Here you can read the clinical assessments in full and see how the Magtrace® lymphatic tracer compares to alternative technologies.
A Meta-analysis showing Magtrace® lymphatic tracer non-inferiority versus ‘conventional techniques’ for SLNB in addition to reporting on a multicentre prospective trial
The Sentimag® probe is a safe SLN identification method and has a low risk of complications
This study evaluates the feasibility of using MRI following the administration of the Magtrace® lymphatic tracer for pre-operative localization of SLN’s and its potential for non-invasive identification of lymph node metastases
If you would like to read additional literature relating to the Magtrace® lymphatic tracer and its safety, effectiveness and clinical results, please get in touch and we will be happy to assist you.